All News

Researchers may have found a potential new way to treat patients with ovarian or lung cancer who had previously failed other treatments, according to early trial findings published in Annals of Oncology.

Perhaps the last thing anybody wants to think about during chemo is a sewer system. If you live in a rural area, however, getting advice about how to pamper your septic system can be helpful.

Take a look at the top 5 CURE stories of August 2018 in this video.

The Food and Drug Administration (FDA) granted priority review to a new supplemental biologics license application for Keytruda (pembrolizumab) to treat adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, according to Merck, the agent’s manufacturer.

One of the things I think about is the future. All cancer patients know we have two futures: One where things go well, and one where they don't.

Stromal cells – known to provide structure to one’s organs – found in bladder cancer may explain why some patients do not respond to Opdivo (nivolumab) treatment.

Cancer would alter the course of my life, but first it would alter the course of my marriage.

Some patients eligible for bladder surgery due to cancer may safely opt to preserve the organ.

Family history was one indicator that a man should undergo periodic screening, but it wasn’t until a couple of decades ago that scientists confirmed a link between inherited mutations of the BRCA gene and the development of prostate cancer.

Two-time cancer survivor shares how journaling can help get you through cancer.

A cancer survivor examines some feline facts and fantasies about animals that could sniff out cancer.

After chemotherapy, immunotherapy has become the standard treatment for bladder cancer. Will it ever play a bigger role?

I know that once you are a cancer survivor, you're always a cancer survivor, but will that sinking feeling of no control ever go away?

The Foundation for Women’s Cancer Continues the Fight to End Gynecologic Cancer One Step at a Time; Race Set for Nov. 4, 2018 in Washington, DC

Sequels always go bigger - and the Band of Ballers continues to grow

While there is currently no definitive way to predict who will respond and who will not, researchers at Brighton and Sussex Medical School in the United Kingdom are working on a blood test that could identify about half of those who may not.

Every year since 1994, we celebrate breast cancer awareness during the month of October. It's a special time of education and celebration. Learn more in this article.

Move over, Avengers. There's a new superhero crew coming through.

Deferring treatment may actually be beneficial for some patients with mantle cell lymphoma (MCL), according to recent research.

In recent years, treatment has expanded for mutations that are well-understood in this space.

Microsatellite instability is a genetic condition that could be difficult to understand. We broke it down to explain how it works.

The researchers found that the trial that led to the guidelines – which recommend screening based on age and smoking history – did not include fair representation from all groups across the nation.

Waiting to hear if one’s blood is showing any signs of the monster’s return has never been easy.